T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection
Musvosvi M, et al.
April 2023
Authors and Affiliates
Munyaradzi Musvosvi #1, Huang Huang #2, Chunlin Wang 2, Qiong Xia 2, Virginie Rozot 1, Akshaya Krishnan 3, Peter Acs 3, Abhilasha Cheruku 3, Gerlinde Obermoser 3, Alasdair Leslie 4,5,6, Samuel M Behar 7, Willem A Hanekom 1,4,5, Nicole Bilek 1, Michelle Fisher 1, Stefan H E Kaufmann 8,9,10, Gerhard Walzl 11, Mark Hatherill 1, Mark M Davis #2,12,13, Thomas J Scriba #14;
1 South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
2 Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
3 Human Immune Monitoring Center, Stanford University, Stanford, CA, USA.
4 Africa Health Research Institute, Durban, South Africa.
5 School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
6 Department of Infection and Immunity, University College London, London, UK.
7 Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School, Worcester, MA, USA.
8 Max Planck Institute for Infection Biology, Berlin, Germany.
9 Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
10 Hagler Institute for Advanced Study, Texas A&M University, College Station, TX, USA.
11 DST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
12 Howard Hughes Medical Institute, Stanford University, Stanford, CA, USA.
13 Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.
14 South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa. thomas.scriba@uct.ac.za.
#Contributed equally.